Act Capital Management, LLC Marker Therapeutics, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Marker Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 354,400 shares of MRKR stock, worth $1.21 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
354,400
Previous 354,400
-0.0%
Holding current value
$1.21 Million
Previous $117,000
11.97%
% of portfolio
0.18%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding MRKR
# of Institutions
5Shares Held
475KCall Options Held
0Put Options Held
0-
Ar Asset Management Inc73.7KShares$252,0540.05% of portfolio
-
Personal Capital Advisors Corp25.7KShares$87,9350.0% of portfolio
-
American Portfolios Advisors Holbrook, NY21.2KShares$72,4010.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Marker Therapeutics, Inc.
- Ticker MRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,599,200
- Market Cap $286M
- Description
- Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...